A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.
Clinical trial NCT00717405 · COMPLETED
Trial details
- NCT number
- NCT00717405
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2010-04-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.